NewAmsterdam Pharma Company
NAMS
#4437
Rank
ยฃ1.48 B
Marketcap
ยฃ16.03
Share price
1.27%
Change (1 day)
111.13%
Change (1 year)

NewAmsterdam Pharma Company (NAMS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : ยฃ47.73 Million

According to NewAmsterdam Pharma Company's latest financial reports the company's total liabilities are ยฃ47.73 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

NewAmsterdam Pharma Company - Total liabilities on balance sheet (from 2023 to 2023)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ46.07 M7.31%
2022-12-31ยฃ42.94 M352.46%
2021-12-31ยฃ9.49 M-33.24%
2020-12-31ยฃ14.21 M